The beneficial effects of sodium glucose co-transporter-2 inhibitor in type 2 diabetes patients with multiple risk factors needs to be explored further: a meta-analysis
Event:
ESC Preventive Cardiology 2023
Topic:
Cardiovascular Disease in Special Populations, Other
Session:
Moderated ePoster 31